1. |
Chu LC, Goggins MG, Fishman EK. Diagnosis and detection of pancreatic cancer. Cancer J, 2017, 23(6): 333-342.
|
2. |
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin, 2019, 69(1): 7-34.
|
3. |
McGuigan A, Kelly P, Turkington RC, et al. Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol, 2018, 24(43): 4846-4861.
|
4. |
Havens JM, Columbus AB, Seshadri AJ, et al. Malnutrition at intensive care unit admission predicts mortality in emergency general surgery patients. JPEN J Parenter Enteral Nutr, 2018, 42(1): 156-163.
|
5. |
Sakurai K, Ohira M, Tamura T, et al. Predictive potential of preoperative nutritional status in long-term outcome projections for patients with gastric cancer. Ann Surg Oncol, 2016, 23(2): 525-533.
|
6. |
Asaoka T, Miyamoto A, Maeda S, et al. Prognostic impact of preoperative NLR and CA19-9 in pancreatic cancer. Pancreatology, 2016, 16(3): 434-440.
|
7. |
Riauka R, Ignatavicius P, Barauskas G. Preoperative platelet to lymphocyte ratio as a prognostic factor for resectable pancreatic cancer: a systematic review and meta-analysis. Dig Surg, 2020, 37(6): 447-455.
|
8. |
Murthy P, Zenati MS, Al Abbas AI, et al. Prognostic value of the systemic immune-inflammation index (SII) After neoadjuvant therapy for patients with resected pancreatic cancer. Ann Surg Oncol, 2020, 27(3): 898-906.
|
9. |
Zhang K, Hua YQ, Wang D, et al. Systemic immune-inflammation index predicts prognosis of patients with advanced pancreatic cancer. J Transl Med, 2019, 17(1): 30.
|
10. |
Aziz MH, Sideras K, Aziz NA, et al. The systemic-immune-inflammation index independently predicts survival and recurrence in resectable pancreatic cancer and its prognostic value depends on bilirubin levels: a retrospective multicenter cohort study. Ann Surg, 2019, 270(1): 139-146.
|
11. |
Hong X, Cui B, Wang M, et al. Systemic immune-inflammation index, based on platelet counts and neutrophil-lymphocyte ratio, is useful for predicting prognosis in small cell lung cancer. Tohoku J Exp Med, 2015, 236(4): 297-304.
|
12. |
Wang K, Diao F, Ye Z, et al. Prognostic value of systemic immune-inflammation index in patients with gastric cancer. Chin J Cancer, 2017, 36(1): 75.
|
13. |
Harimoto N, Yoshizumi T, Sakata K, et al. Prognostic significance of preoperative controlling nutritional status (CONUT) score in patients undergoing hepatic resection for hepatocellular carcinoma. World J Surg, 2017, 41(11): 2805-2812.
|
14. |
Ahiko Y, Shida D, Horie T, et al. Controlling nutritional status (CONUT) score as a preoperative risk assessment index for older patients with colorectal cancer. BMC Cancer, 2019, 19(1): 946.
|
15. |
Kuroda D, Sawayama H, Kurashige J, et al. Controlling nutritional status (CONUT) score is a prognostic marker for gastric cancer patients after curative resection. Gastric Cancer, 2018, 21(2): 204-212.
|
16. |
Jomrich G, Gruber ES, Winkler D, et al. Systemic immune-inflammation index (SII) predicts poor survival in pancreatic cancer patients undergoing resection. J Gastrointest Surg, 2020, 24(3): 610-618.
|
17. |
Shoji F, Haratake N, Akamine T, et al. The preoperative controlling nutritional status score predicts survival after curative surgery in patients with pathological stage Ⅰ non-small cell lung cancer. Anticancer Res, 2017, 37(2): 741-747.
|
18. |
Elinav E, Nowarski R, Thaiss CA, et al. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer, 2013, 13(11): 759-771.
|
19. |
Atsumi T, Singh R, Sabharwal L, et al. Inflammation amplifier, a new paradigm in cancer biology. Cancer Res, 2014, 74(1): 8-14.
|
20. |
Martin HL, Ohara K, Kiberu A, et al. Prognostic value of systemic inflammation-based markers in advanced pancreatic cancer. Intern Med J, 2014, 44(7): 676-682.
|
21. |
Houghton AM, Rzymkiewicz DM, Ji H, et al. Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth. Nat Med, 2010, 16(2): 219-223.
|
22. |
Pillay J, Kamp VM, van Hoffen E, et al. A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J Clin Invest, 2012, 122(1): 327-336.
|
23. |
Hilbig A, Oettle H. Transforming growth factor beta in pancreatic cancer. Curr Pharm Biotechnol, 2011, 12(12): 2158-2164.
|
24. |
Hu B, Yang XR, Xu Y, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res, 2014, 20(23): 6212-6222.
|
25. |
Mao YS, Hao SJ, Zou CF, et al. Controlling nutritional status score is superior to prognostic nutritional index score in predicting survival and complications in pancreatic ductal adenocarcinoma: a Chinese propensity score matching study. Br J Nutr, 2020, 124(11): 1190-1197.
|
26. |
Li H, Wang Z, Yang F, et al. Development and validation of a nomogram for predicting cancer-specific survival of surgical resected stage Ⅰ–Ⅱ adenosquamous carcinoma of the lung. J Surg Oncol, 2020, 121(6): 1027-1035.
|